At last, some news ... I’ve been critical of OPT’s lack of communication with its owners, but on the other hand do I want a bunch of white-shoe brigade cowboys running this process or detail-oriented medical research experts with an eye to methodical process...? Easy choice. A stock only for the very patient, but if OPT were to surprise - especially on that last point about the next 12 months regarding opportunities with pharmaceutical companies - then I think the overwhelming bias is towards the upside...
Ann: Opthea Half Year Report and Accounts, page-8
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $473.9M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 38.0¢ | $142.7K | 370.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49829 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 87450 | 3 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |